SHIP1, an important regulator of the innate system, is a primary target of miR-155 and its repression influences an increase in granulocyte/monocyte cell populations and a reduction in lymphocyte numbers (208, 209) and reduced levels of SHIP1 appears to induce myeloproliferative disorders (208). This evidence concerns the gene INPP5D and myeloproliferative disorder.